BSE Live
Nov 24, 16:01Prev. Close
396.40
Open Price
397.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 24, 15:58Prev. Close
396.85
Open Price
397.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
395.25 (2475)
| Cash Flow of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 | |
| Net CashFlow From Operating Activities | 623.90 | -123.20 | 219.30 | 47.60 | 478.40 | |
| Net Cash Used In Investing Activities | -991.80 | -296.40 | -1,177.80 | -305.60 | -618.30 | |
| Net Cash Used From Financing Activities | 494.80 | 343.60 | 1,039.40 | 112.00 | 27.80 | |
| Foreign Exchange Gains / Losses | 0.30 | 1.70 | 4.70 | 3.50 | -9.40 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 127.20 | -74.30 | 85.60 | -142.50 | -121.50 | |
| Cash And Cash Equivalents Begin of Year | 122.30 | 196.60 | 111.00 | 253.50 | 375.00 | |
| Cash And Cash Equivalents End Of Year | 249.50 | 122.30 | 196.60 | 111.00 | 253.50 |
20.11.2025
Biocon falls 5% after Citi double downgrades stock to 'Sell'; Check latest target price
19.11.2025
Biocon Consolidated September 2025 Net Sales at Rs 4,295.50 crore, up 19.64% Y-o-Y
18.11.2025
18.11.2025